1) Strategy & Leadership - HCA Healthcare's leadership emphasized adaptability in a dynamic environment, with a focus on cost savings and enhancing network execution. - The company is committed to a broad resiliency plan aimed at offsetting impacts from payer mix shifts and improving operational capabilities. - Digital transformation and AI initiatives are progressing, with key rollouts to enhance patient care and operational efficiency.

2) Financial & Segment Results - Revenue increased by 4.3% YoY, while adjusted EBITDA rose nearly 2%. Diluted earnings per share, as adjusted, increased by approximately 11%. - Same-facility volume comparisons showed: - Admissions up 0.9% - Equivalent admissions up 1.3% - Inpatient surgeries down 0.3% - Outpatient surgeries down 1.7% - ER visits increased 0.3% - The first quarter was impacted by a 42% decline in respiratory-related admissions and a 32% drop in respiratory-related ER visits compared to the previous year.

3) Problems / Headwinds - Adverse weather conditions, particularly a winter storm in January, negatively impacted volumes, reducing admissions and ER visits by an estimated 30 basis points and 50 basis points, respectively. - The company faced a $180 million adjusted EBITDA impact from the combination of lower respiratory volumes and the winter storm. - A significant decline in exchange equivalent adjusted admissions by 15% was noted, with an increase in uninsured equivalent admissions by 16%.

4) Operational or Product Plans - HCA Healthcare expanded its network by over 4% in sites of care, increased hospital beds by nearly 1%, and added 4% to emergency room capacity. - The company plans to continue significant capital investments, with $1.1 billion in capital expenditures for the quarter and $1.57 billion in share repurchases. - The outlook for the remainder of the year remains in line with original guidance, anticipating a 2% to 3% volume growth.

5) Guidance & Outlook / Investor Angle - The company reaffirmed its full-year guidance despite the first quarter's challenges, with expectations for adjusted EBITDA remaining in the range of $600 million to $900 million. - The impact of Medicaid supplemental payment programs was better than expected, with a net benefit of approximately $200 million for the quarter. - Future guidance will continue to monitor the dynamic exchange environment and its effects on volumes and payer mix.

Bottom line: HCA Healthcare demonstrated resilience in Q1 2026, navigating headwinds from lower respiratory volumes and adverse weather while achieving solid revenue and earnings growth. The company remains confident in its strategic initiatives and guidance for the year, positioning itself well for future growth despite ongoing challenges in the healthcare landscape.